Levocetirizine: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Administration Contraindications Special Precautions Adverse Reactions Pregnancy Category (US FDA) Overdosage Drug Interactions Food Interaction Action Storage CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Generic Medicine Info

Administration

Levocetirizine: May be taken with or without food.

Contraindications

ESRD (CrCl < 10 mL/min) or undergoing haemodialysis.

Special Precautions

Patient with increased risk of urinary retention (e.g. spinal cord lesion, prostatic hyperplasia), epileptic patients and at risk of convulsion. Children. Mild to moderate renal impairment. Pregnancy and lactation. Patient Counselling This drug may cause somnolence, fatigue and asthenia, if affected, do not drive or operate machinery. Monitoring Parameters Monitor renal function.

Adverse Reactions

Significant: CNS depression, rebound pruritus. Ear and labyrinth disorders: Otitis media. Gastrointestinal disorders: Dry mouth, diarrhoea, vomiting, constipation, abdominal pain. General disorders and administration site conditions: Fatigue, asthenia, pyrexia. Nervous system disorders: Headache. Psychiatric disorders: Sleep disorder, somnolence. Respiratory, thoracic and mediastinal disorders: Nasopharyngitis, pharyngitis, cough. Vascular disorders: Epistaxis.

Pregnancy Category (US FDA)

Drug Interactions

Possible additive adverse CNS effects with CNS depressants (e.g. sedatives, tranquilizers).

CIMS Class

Antihistamines & Antiallergics

ATC Classification

R06AE09 - levocetirizine ; Belongs to the class of piperazine derivatives used as systemic antihistamines.

Disclaimer: This information is independently developed by CIMS based on levocetirizine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2023 CIMS. All rights reserved. Powered by CIMSAsia.com